Literature DB >> 1396749

Use of molecular methods to characterize Moraxella catarrhalis strains in a suspected outbreak of nosocomial infection.

M G Morgan1, H McKenzie, M C Enright, M Bain, F X Emmanuel.   

Abstract

Sodium dodecyl sulphate-polyacrylamide gel electrophoresis of whole cell protein, immunoblotting with normal human serum and restriction endonuclease analysis using Taq I enzyme were applied to 38 clinically significant isolates of Moraxella (Branhamella) catarrhalis obtained during a suspected outbreak of nosocomial infection. Each of 18 strains had individual profiles by at least two of the three methods (unique strains). The remaining 20 strains were assigned to five groups (A-E) on the basis of similarity by at least two of the three methods. Isolates within groups A, D and E were homologous by all three methods. Immunoblot groups B and C had two distinct whole cell protein profiles (B1 and B2) but indistinguishable restriction endonuclease profiles (group B/C). This emphasizes the need to use more than one technique in characterizing strains from suspected outbreaks of nosocomial infection. Grouped strains were more likely to originate from the same hospital ward than unique strains and were associated with a significantly longer median time from patient admission to strain isolation (14 versus 3.5 days, p less than 0.005). Furthermore, the beta-lactamase activity was homologous within the groups. The results suggest that nosocomial infection involving several distinct Moraxella catarrhalis strains persisted over a period of months, involving at least 20 patients on three different wards. Such infection is probably common in wards harbouring suitably predisposed patients. The mode of transmission remains to be elucidated, but the above three techniques possess sufficient reproducibility and discriminatory ability to constitute suitable investigative tools.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1396749     DOI: 10.1007/bf01962069

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  30 in total

1.  A descriptive study of 42 cases of Branhamella catarrhalis pneumonia.

Authors:  P W Wright; R J Wallace; J R Shepherd
Journal:  Am J Med       Date:  1990-05-14       Impact factor: 4.965

2.  Phenotypic characteristics of Branhamella catarrhalis strains.

Authors:  J L Soto-Hernandez; S Holtsclaw-Berk; L M Harvill; S L Berk
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

3.  Nosocomial Branhamella catarrhalis in a paediatric intensive care unit: risk factors for disease.

Authors:  P P Cook; D W Hecht; D R Snydman
Journal:  J Hosp Infect       Date:  1989-04       Impact factor: 3.926

4.  Bronchopulmonary infection due to Branhamella catarrhalis: 11 cases assessed by transtracheal puncture.

Authors:  G Ninane; J Joly; M Kraytman
Journal:  Br Med J       Date:  1978-02-04

5.  Branhamella catarrhalis as a human pathogen and a possible hospital infectant.

Authors:  B Brzin
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1981

6.  Clinical and microbiological features of Branhamella catarrhalis bronchopulmonary infections.

Authors:  N J Slevin; J Aitken; P E Thornley
Journal:  Lancet       Date:  1984-04-07       Impact factor: 79.321

7.  Bronchopulmonary infection due to Branhamella catarrhalis.

Authors:  D T McLeod; F Ahmad; J T Power; M A Calder; A Seaton
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-12

8.  A nosocomial outbreak of Branhamella catarrhalis confirmed by restriction endonuclease analysis.

Authors:  T F Patterson; J E Patterson; B L Masecar; G E Barden; W J Hierholzer; M J Zervos
Journal:  J Infect Dis       Date:  1988-05       Impact factor: 5.226

9.  Temporal study of staphylococcal species on the skin of human subjects in isolation and clonal analysis of Staphylococcus capitis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  A F Maggs; T H Pennington
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

10.  [Hydrolysis of tributyrin by species of "Neisseria" and "Branhamella" (author's transl)].

Authors:  J Y Riou; J Buissière; M Guibourdenche; G Brault; J P Carlier
Journal:  Ann Microbiol (Paris)       Date:  1981 Mar-Apr
View more
  8 in total

1.  Epidemiological typing of Moraxella catarrhalis by pulsed field gel electrophoresis.

Authors:  S M Davison; D E Low; R H Cruz; D Beaulieu; S R Scriver
Journal:  Can J Infect Dis       Date:  1995-05

Review 2.  Lung infections. 2. Branhamella catarrhalis: epidemiological and clinical aspects of a human respiratory tract pathogen.

Authors:  T F Murphy
Journal:  Thorax       Date:  1998-02       Impact factor: 9.139

Review 3.  Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.

Authors:  S Sethi; T F Murphy
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

Review 4.  Moraxella catarrhalis: from emerging to established pathogen.

Authors:  Cees M Verduin; Cees Hol; André Fleer; Hans van Dijk; Alex van Belkum
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

Review 5.  Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response.

Authors:  T F Murphy
Journal:  Microbiol Rev       Date:  1996-06

6.  Antigenic structure of outer membrane protein E of Moraxella catarrhalis and construction and characterization of mutants.

Authors:  T F Murphy; A L Brauer; N Yuskiw; T J Hiltke
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

7.  Comparison of randomly amplified polymorphic DNA analysis and pulsed-field gel electrophoresis for typing of Moraxella catarrhalis strains.

Authors:  H Vu-Thien; C Dulot; D Moissenet; B Fauroux; A Garbarg-Chenon
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

8.  Epidemiological typing of Moraxella catarrhalis by using DNA probes.

Authors:  D Beaulieu; S Scriver; M G Bergeron; D E Low; T R Parr; J E Patterson; A Matlow; P H Roy
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.